Gemcitabine-induced tumor lysis syndrome caused by recurrent breast cancer in a patient without hemodialysis

Japanese Journal of Cancer and Chemotherapy

Volumn 40, Issue 11, 2013, Pages 1529-1532

  Kawaguchi, Aya ^a,b   Hattori, Masaya ^a   Kohno, Norio ^b   Kaise, Hiroshi ^b   Iwata, Hiroji ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Gemcitabine hydrochloride (GEM); Rasburicase; Tumor lysis syndrome (TLS)

Indexed keywords

ANTINEOPLASTIC AGENT; DOCETAXEL; DRUG ADMINISTRATION; DRUG COMBINATION; DRUG THERAPY; GEMCITABINE; OTERACIL; RASBURICASE; S 1 (COMBINATION); TAXOID; TEGAFUR; ANTINEOPLASTIC ANTIMETABOLITE; DEOXYCYTIDINE;

ADULT; AGED; ANEMIA; ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER SURGERY; CASE REPORT; CONSCIOUSNESS LEVEL; DISEASE COURSE; DISEASE FREE INTERVAL; DISEASE SEVERITY; DRUG COMBINATION; DRUG EFFICACY; DRUG THERAPY; FEMALE; GASTRECTOMY; HEMODIALYSIS; HUMAN; HYPERCALCEMIA; HYPERURICEMIA; KIDNEY DYSFUNCTION; LIVER DYSFUNCTION; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; STOMACH NEOPLASMS; SURGERY; TREATMENT DURATION; TUMOR LYSIS SYNDROME; ANALOGS AND DERIVATIVES; BREAST NEOPLASMS; RECURRENT DISEASE;

ADMINISTRATION AND DOSAGE; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; DRUG COMBINATIONS; DRUG THERAPY; GASTRECTOMY; HUMANS; MALE; OXONIC ACID; STOMACH NEOPLASMS; SURGERY; TAXOIDS; TEGAFUR; THERAPEUTIC USE; ANTIMETABOLITES, ANTINEOPLASTIC; BREAST NEOPLASMS; DEOXYCYTIDINE; FEMALE; MIDDLE AGED; RECURRENCE; TUMOR LYSIS SYNDROME;

EID: 84893261422     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Cohen LF, Balow JE, Magrath IT, et al: Acute tumor lysis syndrome. A review of 37 patients with Burkitt's lymphoma. Am J Med 68(4): 486-491, 1980. (Pubitemid 10141811)
2. Stokes DN: The tumour lysis syndrome. Intensive care aspects of paediatric oncology. Anaesthesia 44(2): 133-136, 1989.
3. Jones DP, Mahmoud H and Chesney RW: Tumor lysis syndrome: pathogenesis and management. Pediatr Nephrol 9(2): 206-212, 1955.
4. Coiffier B, Altman A, Pui CH, et al: Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review. J Clin Oncol 26(16): 2767-2778, 2008.
5. Cario MS and Bishop M: Tumour lysis syndrome: new therapeutic strategies and classification. Br J Haematol 127(1): 3-11, 2004.
6. Woo IS, Kim JS, Park MJ, et al: Spontaneous acute tumor lysis syndrome with advanced gastric cancer. J Korean Med Sci 16(1): 115-118, 2001. (Pubitemid 33741329)
7. Tokunou K, Takeda S, Yoshino S, et al: A case of esophageal cancer patient who developed tumor lysis syndrome after chemotherapy. Gan To Kagaku Ryoho 35(12): 2030-2032, 2008.
8. Nikolic-Tomasevic Z, Jelic S, Popov I, et al: Colorectal cancer: dilemmas regarding patient selection and toxicity prediction. J Chemother 12(3): 244-251, 2000.
9. Saintigny P, Chouahnia K, Cohen R, et al: Tumor lysis associated with sudden onset of syndrome of inappropriate antidiuretic hormone secretion. Clin Lung Cancer 8(4): 282-284, 2007. (Pubitemid 46333576)
10. Wright JL, Lin DW, Dewan P, et al: Tumour lysis syndrome in a patient with metastatic, androgen independent prostate cancer. Int J Urol 12(11): 1012-1013, 2005. (Pubitemid 43110244)
11. Yahata T, Nishikawa N, Aoki Y, et al: Tumour lysis syndrome associated with weekly paclitaxel treatment in a case with ovarian cancer. Gynecol Oncol 103(2): 752-754, 2006. (Pubitemid 44602194)
12. Pinder EM, Atwal GS, Ayantunde AA, et al: Tumor Lysis Syndrome Occurring in a Patient with Metastatic Gastrointestinal Stromal Tumor Treated with Glivec (Imatinib Mesylate, Glivec, ST1571). Sarcoma: 82012, 2007.
13. Zigrossi P, Brustia M, Bobbio F, et al: Flare and tumor lysis syndrome with atypical features after letrozole therapy in advanced breast cancer. A case report. Ann Ital Med Int 16(2): 112-117, 2001.
14. Kawai K, Takaoka E, Naoi M, et al: A case of metastatic testicular cancer complicated by tumour lysis syndrome and choriocarcinoma syndrome. Jpn J Clin Oncol 36 (10): 665-667, 2006. (Pubitemid 44697562)
15. Lin CJ, Lim KH, Cheng YC, et al: Tumor lysis syndrome after treatment with gemcitabine for metastatic transitional cell carcinoma Med Oncol 24(4): 455-457, 2007.
16. Ishizawa K, Ogura M, Hamaguchi M, et al: Safety and efficacy of rasburicase (SR29142) in a Japanese phase II study. Cancer Sci 100(2): 357-362, 2009.
17. Pui CH, Mahmoud HH, Wiley JM, et al: Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients with leukemia or lymphoma. J Clin Oncol 19(3): 697-704, 2001. (Pubitemid 32119083)